Tyrosine phosphorylation events during different stages of collagen-platelet activation.
Three groups of phosphoproteins have been distinguished, basing on the velocity and extent of phosphorylation in platelets stimulated with collagen. pp60c-src constituted the first group; the increase in its phosphorylation was the highest and most rapid (maximal in 30 s after the addition of collagen). pp80/85 and non-identified protein of 65 kDa formed the second group; the increase in their phosphorylation was twice smaller than that of pp60c-src, and reached its maximum 60 s after the addition of collagen. pp120, pp72syk, and two non-identified phosphoproteins of 90 and 75 kDa constituted the third group; the increase in their phosphorylation was 4-10-fold lower than that of pp60c-src and reached its maximum after 180 s. We conclude that the phosphorylation of pp60c-src is important for the change of shape of platelets, the phosphorylation of pp80/85 and pp65 for the initiation of the formation of aggregates and the phosphorylation of the third group of phosphoproteins for the formation of massive aggregates. This conclusion was supported by using a monoclonal anti-GPIb antibody, which did not inhibit the shape change of platelets and did not inhibit pp60c-src phosphorylation. This antibody inhibited aggregate formation as well as tyrosine phosphorylation of proteins belonging to the second and the third group of phosphoproteins.
Department of Biophysics, Institute of Physiology and Biochemistry, Medical University of Lodz, Lindleya 3, 90-131 Lodz, Poland.
U
U
Kralisz
C S
CS
Cierniewski
D000818:Animals; D000911:Antibodies, Monoclonal; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism; D003094:Collagen / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D008970:Molecular Weight; D010750:Phosphoproteins / Q000097:blood* / Q000737:chemistry / Q000276:immunology; D010766:Phosphorylation; D015539:Platelet Activation / Q000187:drug effects* / Q000502:physiology*; D010974:Platelet Aggregation / Q000187:drug effects / Q000502:physiology; D019038:Platelet Glycoprotein GPIb-IX Complex / Q000737:chemistry / Q000378:metabolism; D010980:Platelet Membrane Glycoproteins / Q000737:chemistry / Q000378:metabolism; D016392:Proto-Oncogene Proteins pp60(c-src) / Q000097:blood / Q000737:chemistry; D014443:Tyrosine / Q000097:blood*
D000911:Antibodies, Monoclonal; D010750:Phosphoproteins; D019038:Platelet Glycoprotein GPIb-IX Complex; D010980:Platelet Membrane Glycoproteins; D014443:Tyrosine; D003094:Collagen; D016392:Proto-Oncogene Proteins pp60(c-src)